Hepatitis C. Understanding the issues.
Miller
S K
SK
Health Leadership Associates, Potomac, Md., USA.
D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D003663:Decision Trees; D016903:Drug Monitoring; D006526:Hepatitis C / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D017053:Infection Control / Q000379:methods; D016898:Interferon-alpha / Q000627:therapeutic use; D018579:Patient Selection; D016133:Polymerase Chain Reaction; D012254:Ribavirin / Q000627:therapeutic use; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin